“…Relatedly, proteinopathies may target particular neural elements or connection types, rather than brain regions per se: PPA syndromes might, therefore, encompass deficits arising from different functional brain networks, potentially accounting for ‘atypical’ phenotypes (such as the aphasic syndrome associated with GRN mutations [ 15 , 103 , 159 ]). Vulnerability to proteinopathies may be modulated by neurodevelopmental vulnerabilities and genomic profiles, though any relationship is likely to be complex [ 119 , 175 – 179 ].…”